<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34452144</PMID><DateRevised><Year>2021</Year><Month>08</Month><Day>31</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">1999-4923</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>8</Issue><PubDate><Year>2021</Year><Month>Jul</Month><Day>31</Day></PubDate></JournalIssue><Title>Pharmaceutics</Title><ISOAbbreviation>Pharmaceutics</ISOAbbreviation></Journal><ArticleTitle>Polyphenols Epigallocatechin Gallate and Resveratrol, and Polyphenol-Functionalized Nanoparticles Prevent Enterovirus Infection through Clustering and Stabilization of the Viruses.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1182</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/pharmaceutics13081182</ELocationID><Abstract><AbstractText>To efficiently lower virus infectivity and combat virus epidemics or pandemics, it is important to discover broadly acting antivirals. Here, we investigated two naturally occurring polyphenols, Epigallocatechin gallate (EGCG) and Resveratrol (RES), and polyphenol-functionalized nanoparticles for their antiviral efficacy. Concentrations in the low micromolar range permanently inhibited the infectivity of high doses of enteroviruses (10<sup>7</sup> PFU/mL). Sucrose gradient separation of radiolabeled viruses, dynamic light scattering, transmission electron microscopic imaging and an in-house developed real-time fluorescence assay revealed that polyphenols prevented infection mainly through clustering of the virions into very stable assemblies. Clustering and stabilization were not compromised even in dilute virus solutions or after diluting the polyphenols-clustered virions by 50-fold. In addition, the polyphenols lowered virus binding on cells. In silico docking experiments of these molecules against 2- and 3-fold symmetry axes of the capsid, using an algorithm developed for this study, discovered five binding sites for polyphenols, out of which three were novel binding sites. Our results altogether suggest that polyphenols exert their antiviral effect through binding to multiple sites on the virion surface, leading to aggregation of the virions and preventing RNA release and reducing cell surface binding.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Reshamwala</LastName><ForeName>Dhanik</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-0924-076X</Identifier><AffiliationInfo><Affiliation>Department of Biological and Environmental Science/Nanoscience Center, University of Jyv&#xe4;skyl&#xe4;, 40014 Jyv&#xe4;skyl&#xe4;, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shroff</LastName><ForeName>Sailee</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biological and Environmental Science/Nanoscience Center, University of Jyv&#xe4;skyl&#xe4;, 40014 Jyv&#xe4;skyl&#xe4;, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sheik Amamuddy</LastName><ForeName>Olivier</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0002-1781-1382</Identifier><AffiliationInfo><Affiliation>Research Unit in Bioinformatics (RUBi), Department of Biochemistry and Microbiology, Rhodes University, Makhanda 6140, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laquintana</LastName><ForeName>Valentino</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0003-1266-638X</Identifier><AffiliationInfo><Affiliation>Department of Pharmacy-Pharmaceutical Sciences, University of Bari "Aldo Morro", 70125 Bari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Denora</LastName><ForeName>Nunzio</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-7756-7828</Identifier><AffiliationInfo><Affiliation>Department of Pharmacy-Pharmaceutical Sciences, University of Bari "Aldo Morro", 70125 Bari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zacheo</LastName><ForeName>Antonella</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Laboratory for Nanotechnology, IRCCS Istituto Tumori "Giovanni Paolo II", 70124 Bari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lampinen</LastName><ForeName>Vili</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0003-2153-6149</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine and Health Technology, Tampere University, 33520 Tampere, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hytonen</LastName><ForeName>Vesa P</ForeName><Initials>VP</Initials><Identifier Source="ORCID">0000-0002-9357-1480</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine and Health Technology, Tampere University, 33520 Tampere, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fimlab Laboratories, 33520 Tampere, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tastan Bishop</LastName><ForeName>&#xd6;zlem</ForeName><Initials>&#xd6;</Initials><Identifier Source="ORCID">0000-0001-6861-7849</Identifier><AffiliationInfo><Affiliation>Research Unit in Bioinformatics (RUBi), Department of Biochemistry and Microbiology, Rhodes University, Makhanda 6140, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krol</LastName><ForeName>Silke</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-3108-9821</Identifier><AffiliationInfo><Affiliation>Laboratory for Personalized Medicine, National Institute of Gastroenterology, "S. de Bellis" Research Hospital, 70013 Castellana Grotte, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marjom&#xe4;ki</LastName><ForeName>Varpu</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-4592-5926</Identifier><AffiliationInfo><Affiliation>Department of Biological and Environmental Science/Nanoscience Center, University of Jyv&#xe4;skyl&#xe4;, 40014 Jyv&#xe4;skyl&#xe4;, Finland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>not available</GrantID><Agency>Jane ja Aatos Erkon S&#xe4;&#xe4;ti&#xf6;</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>07</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Pharmaceutics</MedlineTA><NlmUniqueID>101534003</NlmUniqueID><ISSNLinking>1999-4923</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">antiviral efficacy</Keyword><Keyword MajorTopicYN="N">enteroviruses</Keyword><Keyword MajorTopicYN="N">functionalized gold nanoparticles</Keyword><Keyword MajorTopicYN="N">polyphenols</Keyword><Keyword MajorTopicYN="N">stabilization</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>6</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>7</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>7</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>8</Month><Day>28</Day><Hour>1</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>8</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>29</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>7</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34452144</ArticleId><ArticleId IdType="pmc">PMC8398301</ArticleId><ArticleId IdType="doi">10.3390/pharmaceutics13081182</ArticleId><ArticleId IdType="pii">pharmaceutics13081182</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Stone V.M., Hankaniemi M.M., Laitinen O.H., Sioofy-Khojine A.B., Lin A., Lozano I.M.D., Mazur M.A., Marjom&#xe4;ki V., Lor&#xe9; K., Hy&#xf6;ty H., et al. A hexavalent Coxsackievirus B vaccine is highly immunogenic and has a strong protective capacity in mice and nonhuman primates. Sci. Adv. 2020;6:eaaz2433. doi: 10.1126/sciadv.aaz2433.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.aaz2433</ArticleId><ArticleId IdType="pmc">PMC7202868</ArticleId><ArticleId IdType="pubmed">32494709</ArticleId></ArticleIdList></Reference><Reference><Citation>Linnakoski R., Reshamwala D., Veteli P., Cortina-Escribano M., Vanhanen H., Marjom&#xe4;ki V. Antiviral Agents From Fungi: Diversity, Mechanisms and Potential Applications. Front. Microbiol. 2018;9:2325. doi: 10.3389/fmicb.2018.02325.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2018.02325</ArticleId><ArticleId IdType="pmc">PMC6176074</ArticleId><ArticleId IdType="pubmed">30333807</ArticleId></ArticleIdList></Reference><Reference><Citation>Filardo S., Di Pietro M., Mastromarino P., Sessa R. Therapeutic potential of resveratrol against emerging respiratory viral infections. Pharmacol. Ther. 2020;214:107613. doi: 10.1016/j.pharmthera.2020.107613.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2020.107613</ArticleId><ArticleId IdType="pubmed">32562826</ArticleId></ArticleIdList></Reference><Reference><Citation>Vestergaard M., Ingmer H. Antibacterial and antifungal properties of resveratrol. Int. J. Antimicrob. Agents. 2019;53:716&#x2013;723. doi: 10.1016/j.ijantimicag.2019.02.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijantimicag.2019.02.015</ArticleId><ArticleId IdType="pubmed">30825504</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., Li Y., Gu Z., Wang Y., Shi M., Ji Y., Sun J., Xu X., Zhang L., Jiang J., et al. Resveratrol Inhibits Enterovirus 71 Replication and Pro-Inflammatory Cytokine Secretion in Rhabdosarcoma Cells through Blocking IKKs/NF-&#x3ba;B Signaling Pathway. PLoS ONE. 2015;10:e0116879.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4333343</ArticleId><ArticleId IdType="pubmed">25692777</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson M., McCormick T.G., Nance C.L., Shearer W. Epigallocatechin gallate, the main polyphenol in green tea, binds to the T-cell receptor, CD4: Potential for HIV-1 therapy. J. Allergy Clin. Immunol. 2006;118:1369&#x2013;1374. doi: 10.1016/j.jaci.2006.08.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2006.08.016</ArticleId><ArticleId IdType="pubmed">17157668</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawai K., Tsuno N.H., Kitayama J., Okaji Y., Yazawa K., Asakage M., Hori N., Watanabe T., Takahashi K., Nagawa H. Epigallocatechin gallate, the main component of tea polyphenol, binds to CD4 and interferes with gp120 binding. J. Allergy Clin. Immunol. 2003;112:951&#x2013;957. doi: 10.1016/S0091-6749(03)02007-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0091-6749(03)02007-4</ArticleId><ArticleId IdType="pubmed">14610487</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim M., Kim S.-Y., Lee H.W., Shin J.S., Kim P., Jung Y.-S., Jeong H.-S., Hyun J.-K., Lee C.-K. Inhibition of influenza virus internalization by (&#x2212;)-epigallocatechin-3-gallate. Antivir. Res. 2013;100:460&#x2013;472. doi: 10.1016/j.antiviral.2013.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2013.08.002</ArticleId><ArticleId IdType="pubmed">23954192</ArticleId></ArticleIdList></Reference><Reference><Citation>Cottart C.-H., Nivet-Antoine V., Laguillier-Morizot C., Beaudeux J.-L. Resveratrol bioavailability and toxicity in humans. Mol. Nutr. Food Res. 2009;54:7&#x2013;16. doi: 10.1002/mnfr.200900437.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mnfr.200900437</ArticleId><ArticleId IdType="pubmed">20013887</ArticleId></ArticleIdList></Reference><Reference><Citation>Ku&#x10d;era O., Mezera V., Moravcova A., Endlicher R., Lotkov&#xe1; H., Drahota Z., &#x10c;ervinkov&#xe1; Z. In VitroToxicity of Epigallocatechin Gallate in Rat Liver Mitochondria and Hepatocytes. Oxidative Med. Cell. Longev. 2015;2015:476180. doi: 10.1155/2015/476180.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/476180</ArticleId><ArticleId IdType="pmc">PMC4397056</ArticleId><ArticleId IdType="pubmed">25918582</ArticleId></ArticleIdList></Reference><Reference><Citation>Isbrucker R., Edwards J., Wolz E., Davidovich A., Bausch J. Safety studies on epigallocatechin gallate (EGCG) preparations. Part 2: Dermal, acute and short-term toxicity studies. Food Chem. Toxicol. 2006;44:636&#x2013;650. doi: 10.1016/j.fct.2005.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fct.2005.11.003</ArticleId><ArticleId IdType="pubmed">16387402</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang F., Medik Y., Li L., Tian X., Fu D., Brouwer K.L.R., Wagner K., Sun B., Sendi H., Mi Y., et al. Nanoparticle Drug Delivery Can Reduce the Hepatotoxicity of Therapeutic Cargo. Small. 2020;16:e1906360. doi: 10.1002/smll.201906360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/smll.201906360</ArticleId><ArticleId IdType="pmc">PMC7873714</ArticleId><ArticleId IdType="pubmed">31972070</ArticleId></ArticleIdList></Reference><Reference><Citation>Mel&#xe9;ndez-Villanueva M.A., Mor&#xe1;n-Santiba&#xf1;ez K., Sanmiguel J.J.M., Rangel-L&#xf3;pez R., Garza-Navarro M.A., Rodr&#xed;guez-Padilla C., Zarate-Trivi&#xf1;o D.G., Trejo-&#xc1;vila L.M. Virucidal Activity of Gold Nanoparticles Synthesized by Green Chemistry Using Garlic Extract. Viruses. 2019;11:1111. doi: 10.3390/v11121111.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11121111</ArticleId><ArticleId IdType="pmc">PMC6950311</ArticleId><ArticleId IdType="pubmed">31801280</ArticleId></ArticleIdList></Reference><Reference><Citation>Huttunen M., Waris M., Kajander R., Hyypi&#xe4; T., Marjom&#xe4;ki V. Coxsackievirus A9 Infects Cells via Nonacidic Multivesicular Bodies. J. Virol. 2014;88:5138&#x2013;5151. doi: 10.1128/JVI.03275-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03275-13</ArticleId><ArticleId IdType="pmc">PMC3993817</ArticleId><ArticleId IdType="pubmed">24574401</ArticleId></ArticleIdList></Reference><Reference><Citation>Myllynen M., Kazmertsuk A., Marjom&#xe4;ki V. A Novel Open and Infectious Form of Echovirus 1. J. Virol. 2016;90:6759&#x2013;6770. doi: 10.1128/JVI.00342-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00342-16</ArticleId><ArticleId IdType="pmc">PMC4944302</ArticleId><ArticleId IdType="pubmed">27194757</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruokolainen V., Domanska A., Laajala M., Pelliccia M., Butcher S.J., Marjom&#xe4;ki V. Extracellular Albumin and Endosomal Ions Prime Enterovirus Particles for Uncoating That Can Be Prevented by Fatty Acid Saturation. J. Virol. 2019;93:599. doi: 10.1128/JVI.00599-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00599-19</ArticleId><ArticleId IdType="pmc">PMC6694817</ArticleId><ArticleId IdType="pubmed">31189702</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S., Bonifacio A., Zanuttin F., Sergo V., Krol S. Synthesis and multidisciplinary characterization of polyelectrolyte multilayer-coated nanogold with improved stability toward aggregation. Colloid Polym. Sci. 2011;289:269&#x2013;280. doi: 10.1007/s00396-010-2343-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00396-010-2343-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Sechi M., Sanna V., Pala N., Manconi P., Mariani A., Dedola S., Rassu M., Crosio C., Iaccarino C., Dessi G. Single-step green synthesis and characterization of gold-conjugated polyphenol nanoparticles with antioxidant and biological activities. Int. J. Nanomed. 2014;9:4935&#x2013;4951. doi: 10.2147/IJN.S70648.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJN.S70648</ArticleId><ArticleId IdType="pmc">PMC4211914</ArticleId><ArticleId IdType="pubmed">25364251</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrone M., Lopalco A., Lopedota A., Cutrignelli A., Laquintana V., Douglas J., Franco M., Liberati E., Russo V., Tongiani S., et al. Preactivated thiolated glycogen as mucoadhesive polymer for drug delivery. Eur. J. Pharm. Biopharm. 2017;119:161&#x2013;169. doi: 10.1016/j.ejpb.2017.06.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejpb.2017.06.011</ArticleId><ArticleId IdType="pubmed">28610879</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidtke M., Schnittler U., Jahn B., Dahse H.-M., Stelzner A. A rapid assay for evaluation of antiviral activity against coxsackie virus B3, influenza virus A, and herpes simplex virus type 1. J. Virol. Methods. 2001;95:133&#x2013;143. doi: 10.1016/S0166-0934(01)00305-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0166-0934(01)00305-6</ArticleId><ArticleId IdType="pubmed">11377720</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruokolainen V., Laajala M., Marjom&#xe4;ki V. Real-time Fluorescence Measurement of Enterovirus Uncoating. Bio-Protocol. 2020;10:e3582. doi: 10.21769/BioProtoc.3582.</Citation><ArticleIdList><ArticleId IdType="doi">10.21769/BioProtoc.3582</ArticleId><ArticleId IdType="pmc">PMC7842371</ArticleId><ArticleId IdType="pubmed">33659552</ArticleId></ArticleIdList></Reference><Reference><Citation>Martikainen M., Salorinne K., Lahtinen T., Malola S., Permi P., H&#xe4;kkinen H., Marjom&#xe4;ki V. Hydrophobic pocket targeting probes for enteroviruses. Nanoscale. 2015;7:17457&#x2013;17467. doi: 10.1039/C5NR04139B.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C5NR04139B</ArticleId><ArticleId IdType="pubmed">26440968</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris G.M., Huey R., Lindstrom W., Sanner M.F., Belew R.K., Goodsell D.S., Olson A.J. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J. Comput. Chem. 2009;30:2785&#x2013;2791. doi: 10.1002/jcc.21256.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcc.21256</ArticleId><ArticleId IdType="pmc">PMC2760638</ArticleId><ArticleId IdType="pubmed">19399780</ArticleId></ArticleIdList></Reference><Reference><Citation>Hendry E., Hatanaka H., Fry E., Smyth M., Tate J., Stanway G., Santti J., Maaronen M., Hyypi&#xe4; T., Stuart D. The crystal structure of coxsackievirus A9: New insights into the uncoating mechanisms of enteroviruses. Structure. 1999;7:1527&#x2013;1538. doi: 10.1016/S0969-2126(00)88343-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0969-2126(00)88343-4</ArticleId><ArticleId IdType="pubmed">10647183</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelnabi R., Geraets J.A., Ma Y., Mirabelli C., Flatt J.W., Domanska A., Delang L., Jochmans D., Kumar T.A., Jayaprakash V., et al. A novel druggable interprotomer pocket in the capsid of rhino- and enteroviruses. PLoS Biol. 2019;17:e3000281. doi: 10.1371/journal.pbio.3000281.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.3000281</ArticleId><ArticleId IdType="pmc">PMC6559632</ArticleId><ArticleId IdType="pubmed">31185007</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassan N.M., Alhossary A.A., Mu Y., Kwoh C. Protein-Ligand Blind Docking using QuickVina-W with Inter-Process Spatio-Temporal Integration. Sci. Rep. 2017;7:15451. doi: 10.1038/s41598-017-15571-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-15571-7</ArticleId><ArticleId IdType="pmc">PMC5684369</ArticleId><ArticleId IdType="pubmed">29133831</ArticleId></ArticleIdList></Reference><Reference><Citation>Tange O. GNU Parallel: The Command-Line Power Tool. Login. 2011;36:42&#x2013;47.</Citation></Reference><Reference><Citation>Jubb H., Higueruelo A., Ochoa-Monta&#xf1;o B., Pitt W., Ascher D.B., Blundell T.L. Arpeggio: A Web Server for Calculating and Visualising Interatomic Interactions in Protein Structures. J. Mol. Biol. 2017;429:365&#x2013;371. doi: 10.1016/j.jmb.2016.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2016.12.004</ArticleId><ArticleId IdType="pmc">PMC5282402</ArticleId><ArticleId IdType="pubmed">27964945</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith R.H.B., Dar A.C., Schlessinger A. PyVOL: A PyMOL Plugin for Visualization, Comparison, and Volume Calculation of Drug-Binding Sites. Biorxiv. 2019:816702. doi: 10.1101/816702.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/816702</ArticleId></ArticleIdList></Reference><Reference><Citation>Muckelbauer J.K., Kremer M., Minor I., Tong L., Zlotnick A., Johnson J.E., Rossmann M.G. Structure determination of coxsackievirus B3 to 3.5 &#xc5; resolution. Acta Crystallogr. Sect. D Biol. Crystallogr. 1995;51:871&#x2013;887. doi: 10.1107/S0907444995002253.</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S0907444995002253</ArticleId><ArticleId IdType="pubmed">15299757</ArticleId></ArticleIdList></Reference><Reference><Citation>Pei J., Kim B.-H., Grishin N.V. PROMALS3D: A tool for multiple protein sequence and structure alignments. Nucleic Acids Res. 2008;36:2295&#x2013;2300. doi: 10.1093/nar/gkn072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkn072</ArticleId><ArticleId IdType="pmc">PMC2367709</ArticleId><ArticleId IdType="pubmed">18287115</ArticleId></ArticleIdList></Reference><Reference><Citation>Waterhouse A.M., Procter J., Martin D., Clamp M., Barton G.J. Jalview Version 2--a multiple sequence alignment editor and analysis workbench. Bioinformatics. 2009;25:1189&#x2013;1191. doi: 10.1093/bioinformatics/btp033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btp033</ArticleId><ArticleId IdType="pmc">PMC2672624</ArticleId><ArticleId IdType="pubmed">19151095</ArticleId></ArticleIdList></Reference><Reference><Citation>Saarnio V.K., Salorinne K., Ruokolainen V.P., Nilsson J.R., Tero T.-R., Oikarinen S., Wilhelmsson L.M., Lahtinen T.M., Marjom&#xe4;ki V.S. Development of functionalized SYBR green II related cyanine dyes for viral RNA detection. Dye. Pigment. 2020;177:108282. doi: 10.1016/j.dyepig.2020.108282.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dyepig.2020.108282</ArticleId></ArticleIdList></Reference><Reference><Citation>Orhan D.D., &#xd6;z&#xe7;elik B., &#xd6;zgen S., Ergun F. Antibacterial, antifungal, and antiviral activities of some flavonoids. Microbiol. Res. 2010;165:496&#x2013;504. doi: 10.1016/j.micres.2009.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micres.2009.09.002</ArticleId><ArticleId IdType="pubmed">19840899</ArticleId></ArticleIdList></Reference><Reference><Citation>Du N., Li X., Bao W., Wang B., Xu G., Wang F. Resveratrol-loaded nanoparticles inhibit enterovirus 71 replication through the oxidative stress-mediated ERS/autophagy pathway. Int. J. Mol. Med. 2019;44:737&#x2013;749. doi: 10.3892/ijmm.2019.4211.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijmm.2019.4211</ArticleId><ArticleId IdType="pubmed">31173159</ArticleId></ArticleIdList></Reference><Reference><Citation>Lv X., Qiu M., Chen D., Zheng N., Jin Y., Wu Z. Apigenin inhibits enterovirus 71 replication through suppressing viral IRES activity and modulating cellular JNK pathway. Antivir. Res. 2014;109:30&#x2013;41. doi: 10.1016/j.antiviral.2014.06.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2014.06.004</ArticleId><ArticleId IdType="pubmed">24971492</ArticleId></ArticleIdList></Reference><Reference><Citation>Pevear D.C., Tull T.M., Seipel M.E., Groarke J.M. Activity of Pleconaril against Enteroviruses. Antimicrob. Agents Chemother. 1999;43:2109&#x2013;2115. doi: 10.1128/AAC.43.9.2109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.43.9.2109</ArticleId><ArticleId IdType="pmc">PMC89431</ArticleId><ArticleId IdType="pubmed">10471549</ArticleId></ArticleIdList></Reference><Reference><Citation>Smyth M.S., Martin J.H. Picornavirus Uncoating. Mol. Pathol. MP. 2002;55:214&#x2013;219. doi: 10.1136/mp.55.4.214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/mp.55.4.214</ArticleId><ArticleId IdType="pmc">PMC1187181</ArticleId><ArticleId IdType="pubmed">12147709</ArticleId></ArticleIdList></Reference><Reference><Citation>Smyth M., Pettitt T., Symonds A., Martin J. Identification of the pocket factors in a picornavirus. Arch. Virol. 2003;148:1225&#x2013;1233. doi: 10.1007/s00705-002-0974-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-002-0974-4</ArticleId><ArticleId IdType="pubmed">12756627</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S., Chen J., Cheng T., Gindulyte A., He J., He S., Li Q., Shoemaker B.A., Thiessen P.A., Yu B., et al. PubChem 2019 update: Improved access to chemical data. Nucleic Acids Res. 2019;47:D1102&#x2013;D1109. doi: 10.1093/nar/gky1033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky1033</ArticleId><ArticleId IdType="pmc">PMC6324075</ArticleId><ArticleId IdType="pubmed">30371825</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira N., Saraiva M.J., Almeida M. Natural polyphenols inhibit different steps of the process of transthyretin (TTR) amyloid fibril formation. FEBS Lett. 2011;585:2424&#x2013;2430. doi: 10.1016/j.febslet.2011.06.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2011.06.030</ArticleId><ArticleId IdType="pubmed">21740906</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira N., Cardoso I., Domingues M.R., Vitorino R., Bastos M., Bai G., Saraiva M.J., Almeida M. Binding of epigallocatechin-3-gallate to transthyretin modulates its amyloidogenicity. FEBS Lett. 2009;583:3569&#x2013;3576. doi: 10.1016/j.febslet.2009.10.062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2009.10.062</ArticleId><ArticleId IdType="pubmed">19861125</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira N., Saraiva M.J., Almeida M.R. Epigallocatechin-3-Gallate as a Potential Therapeutic Drug for TTR-Related Amyloidosis: &#x201c;In Vivo&#x201d; Evidence from FAP Mice Models. PLoS ONE. 2012;7:e29933. doi: 10.1371/journal.pone.0029933.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0029933</ArticleId><ArticleId IdType="pmc">PMC3254632</ArticleId><ArticleId IdType="pubmed">22253829</ArticleId></ArticleIdList></Reference><Reference><Citation>del Amo J.M.L., Fink U., Dasari M., Grelle G., Wanker E.E., Bieschke J., Reif B. Structural Properties of EGCG-Induced, Nontoxic Alzheimer&#x2019;s Disease A&#x3b2; Oligomers. J. Mol. Biol. 2012;421:517&#x2013;524. doi: 10.1016/j.jmb.2012.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2012.01.013</ArticleId><ArticleId IdType="pubmed">22300765</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearson J.P., Chater P.I., Wilcox M.D. The properties of the mucus barrier, a unique gel&#x2013;how can nanoparticles cross it? Ther. Deliv. 2016;7:229&#x2013;244. doi: 10.4155/tde-2015-0002.</Citation><ArticleIdList><ArticleId IdType="doi">10.4155/tde-2015-0002</ArticleId><ArticleId IdType="pubmed">27010985</ArticleId></ArticleIdList></Reference><Reference><Citation>de Sousa I.P., Steiner C., Schmutzler M., Wilcox M.D., Veldhuis G.J., Pearson J.P., Huck C., Salvenmoser W., Bernkop-Schn&#xfc;rch A. Mucus permeating carriers: Formulation and characterization of highly densely charged nanoparticles. Eur. J. Pharm. Biopharm. 2015;97:273&#x2013;279. doi: 10.1016/j.ejpb.2014.12.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejpb.2014.12.024</ArticleId><ArticleId IdType="pubmed">25576256</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>